|
|
News Breaks | | | | February 6, 2013 | | 07:33 EDT |  | RHHBY | FDA warns of new batch of fake Avastin, WSJ reports
The FDA has warned doctors that another counterfeit batch of the cancer drug Avastin has reached medical practices in the U.S., reports the Wall Street Journal. The agency said Pharmalogical, which also does business as Medical Device King and Taranis Medical, had shipped two batches of Altuzan, the Turkish brand-name for Roche Holding's (RHHBY) Avastin, to American customers. At least one batch contained no active ingredient, the agency said.Reference Link | |
|
News For RHHBY From The Last 14 Days Check below for free stories on RHHBY the last two weeks. |
|
|
| June 19, 2013 | | 10:46 EDT | | RHHBY | Alexion mentioned as possible target for Roche in London Times
Reference Link | | | 08:45 EDT |  | RHHBY | Leerink's biotech analyst holds analyst/industry conference call on ADA
Analyst Antlaffy, along with Dr. George Grunberger, founder & Chairman of the Grunberger Diabetes Institute, preview the upcoming American Diabetes Association's conference, including perspectives on new devices in diabetes, potential disruptive technologies at ADA and progress towards the artificial pancreas on an Analyst/Industry conference call to be held on June 20 at 2 pm. | | | June 13, 2013 | | 11:02 EDT | | RHHBY | Leerink's major pharma analyst holds an analyst/Industry conference call
 Subscribe for More Information | | | June 11, 2013 | | 08:01 EDT | | RHHBY | Leerink's major pharma and biotech analysts hold a conference call
Subscribe for More Information | | | June 10, 2013 | | 07:40 EDT | | RHHBY | Leerink's biotech analyst holds analyst/industry conference call on ASCO
Subscribe for More Information | | | 07:24 EDT | | RHHBY | European Society of Human Genetics to host a conference
Subscribe for More Information | |
|
|
|
|
|
|
